The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway
Open accessAbstract
// Chengcao Sun 1 , Shujun Li 1, 2 , Feng Zhang 1 , Yongyong Xi 1 , Liang Wang 1 , Yongyi Bi 1 , Dejia Li 1 1 Department of Occupational and Environmental Health, School of Public Health, Wuhan University, Wuhan, P. R. China 2 Wuhan Hospital for the Prevention and Treatment of Occupational Diseases, Wuhan, P. R. China Correspondence to: Dejia Li, email: lodjlwhu@sina.com Keywords: long non-coding RNA NEAT1 (lncRNA NEAT1), hsa-miRNA-377-3p (miR-377-3p), E2F3 , non-small cell lung cancer (NSCLC), tumorigenesis Received: February 16, 2016 Accepted: May 05, 2016 Published: June 16, 2016 ABSTRACT Recently, the long non-coding RNA (lncRNA) NEAT1 has been identified as an oncogenic gene in multiple cancer types and elevated expression of NEAT1 was tightly linked to tumorigenesis and cancer progression. However, the molecular basis for this observation has not been characterized in progression of non-small cell lung cancer (NSCLC). In our studies, we identified NEAT1 was highly expressed in patients with NSCLC and was a novel regulator of NSCLC progression. Patients whose tumors had high NEAT1 expression had a shorter overall survival than patients whose tumors had low NEAT1 expression. Further, NEAT1 significantly accelerates NSCLC cell growth and metastasis in vitro and tumor growth in vivo. Additionally, by using bioinformatics study and RNA pull down combined with luciferase reporter assays, we demonstrated that NEAT1 functioned as a competing endogenous RNA (ceRNA) for hsa-miR-377-3p, antagonized its functions and led to the de-repression of its endogenous targets E2F3, which was a core oncogene in promoting NSCLC progression. Taken together, these observations imply that the NEAT1 modulated the expression of E2F3 gene by acting as a ceRNA, which may build up the missing link between the regulatory miRNA network and NSCLC progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Sun, C., Li, S., Yang, C.-L., Xue, R., Xi, Y., Wang, L., Zhao, Q.-L., & Li, D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.655019 · Cited by 148
Self-citationRetractedHsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met
Sun, C., Sang, M., Li, S., Sun, X., Yang, C., Xi, Y., Wang, L., Zhang, F., Bi, Y., Fu, Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5476 · Cited by 116
Self-citationRetractedSun, C., Li, S., & Li, D. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00721.2015 · Cited by 91
Self-citationRetractedSulforaphane alleviates muscular dystrophy inmdxmice by activation of Nrf2
Sun, C., Yang, C., Xue, R., Li, S., Zhang, T., Pan, L., Ma, X., Wang, L., & Li, D. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00744.2014 · Cited by 83
Self-citationRetractedWAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Long non-coding RNAs: insights into functions
Mercer, T. R., Dinger, M. E., & Mattick, J. S. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2521 · Cited by 5,654
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,218
Stöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
Molecular Mechanisms of Long Noncoding RNAs
Wang, K. C., & Chang, H. Y. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.018 · Cited by 4,396
Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.022 · Cited by 4,244
Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes
Tsai, M.-C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J. K., Lan, F., Shi, Y., Segal, E., & Chang, H. Y. (2010) · Science · doi:10.1126/science.1192002 · Cited by 3,290
A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M. J., Kenzelmann-Broz, D., Khalil, A. M., Zuk, O., Amit, I., Rabani, M., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.040 · Cited by 2,053
Long Noncoding RNAs with Enhancer-like Function in Human Cells
Ørom, U. A., Derrien, T., Beringer, M., Gumireddy, K., Gardini, A., Bussotti, G., Lai, F., Zytnicki, M., Notredame, C., Huang, Q., et al. (2010) · Cell · doi:10.1016/j.cell.2010.09.001 · Cited by 1,721
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
Yuan, J.-H., Yang, F., Wang, F., Ma, J.-Z., Guo, Y.-J., Tao, Q.-F., Liu, F., Pan, W., Wang, T.-T., Zhou, C.-C., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.010 · Cited by 1,515
Clemson, C. M., Hutchinson, J. N., Sara, S. A., Ensminger, A. W., Fox, A. H., Chess, A., & Lawrence, J. B. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.026 · Cited by 1,445
Yap, K. L., Li, S., Muñoz-Cabello, A. M., Raguz, S., Zeng, L., Mujtaba, S., Gil, J., Walsh, M. J., & Zhou, M.-M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.03.021 · Cited by 1,391
Self-citationCyclin D as a therapeutic target in cancer
Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370
Kino, T., Hurt, D. E., Ichijo, T., Nader, N., & Chrousos, G. P. (2010) · Science Signaling · doi:10.1126/scisignal.2000568 · Cited by 1,231
Prensner, J. R., Iyer, M. K., Balbin, O. A., Dhanasekaran, S. M., Cao, Q., Brenner, J. C., Laxman, B., Asangani, I. A., Grasso, C. S., Kominsky, H. D., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1914 · Cited by 1,029
Inhibition of cyclin-dependent kinases by p21.
Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., & Swindell, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.4.387 · Cited by 1,023
Hutchinson, J. N., Ensminger, A. W., Clemson, C. M., Lynch, C. R., Lawrence, J. B., & Chess, A. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-39 · Cited by 996
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., & Schmidt, E. V. (1994) · Nature · doi:10.1038/369669a0 · Cited by 965
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis
Sicinski, P., Donaher, J. L., Geng, Y., Parker, S. B., Gardner, H., Park, M. Y., Robker, R. L., Richards, J. S., McGinnis, L. K., Biggers, J. D., et al. (1996) · Nature · doi:10.1038/384470a0 · Cited by 697
Chen, L.-L., & Carmichael, G. G. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.027 · Cited by 659
Sunwoo, H., Dinger, M. E., Wilusz, J. E., Amaral, P. P., Mattick, J. S., & Spector, D. L. (2009) · Genome Research · doi:10.1101/gr.087775.108 · Cited by 655
Yang, F., Zhang, L., Huo, X.-S., Yuan, J.-H., Xu, D., Yuan, S.-X., Zhu, N., Zhou, W.-P., Yang, G.-S., Wang, Y.-Z., et al. (2011) · Hepatology · doi:10.1002/hep.24563 · Cited by 632
Self-citationThe oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer
Chakravarty, D., Sboner, A., Nair, S. S., Giannopoulou, E., Li, R., Hennig, S., Mosquera, J. M., Pauwels, J., Park, K., Kossai, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms6383 · Cited by 621
Takahashi, Y., Rayman, J. B., & Dynlacht, B. D. (2000) · Genes & Development · doi:10.1101/gad.14.7.804 · Cited by 621
Pasmant, E., Laurendeau, I., Héron, D., Vidaud, M., Vidaud, D., & Bièche, I. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2004 · Cited by 618
DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.
de Kok, J. B., Verhaegh, G. W. C. T., Roelofs, R., Hessels, D., Kiemeney, L. A. L. M., Aalders, T. W., Swinkels, D. W., & Schalken, J. A. (2002) · PubMed · Cited by 607
MENε/β noncoding RNAs are essential for structural integrity of nuclear paraspeckles
Sasaki, Y. T. F., Ideue, T., Sano, M., Mituyama, T., & Hirose, T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807899106 · Cited by 604
E2F target genes: unraveling the biology
Bracken, A. P., Ciro, M., Cocito, A., & Helin, K. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.06.006 · Cited by 576
Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis
DeGregori, J., & Johnson, D. (2006) · Current Molecular Medicine · doi:10.2174/1566524010606070739 · Cited by 498
Yang, F., Huo, X.-S., Yuan, S.-X., Zhang, L., Zhou, W.-P., Wang, F., & Sun, S.-H. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.010 · Cited by 477
Wang, F., Yuan, J.-H., Wang, S.-B., Yang, F., Yuan, S.-X., Ye, C., Yang, N., Zhou, W.-P., Li, W.-L., Li, W., et al. (2014) · Hepatology · doi:10.1002/hep.27239 · Cited by 440
Yuan, S., Wang, J., Yang, F., Tao, Q., Zhang, J., Wang, L., Yang, Y., Liu, H., Wang, Z., Xu, Q., et al. (2016) · Hepatology · doi:10.1002/hep.27893 · Cited by 404
Self-citationYuan, S.-X., Yang, F., Yang, Y., Tao, Q.-F., Zhang, J., Huang, G., Yang, Y., Wang, R.-Y., Yang, S., Huo, X.-S., et al. (2012) · Hepatology · doi:10.1002/hep.25895 · Cited by 374
Pandey, G. K., Mitra, S., Subhash, S., Hertwig, F., Kanduri, M., Mishra, K., Fransson, S., Ganeshram, A., Mondal, T., Bandaru, S., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.014 · Cited by 343
E2f3 is critical for normal cellular proliferation
Humbert, P. O., Verona, R., Trimarchi, J. M., Rogers, C., Dandapani, S., & Lees, J. A. (2000) · Genes & Development · doi:10.1101/gad.14.6.690 · Cited by 337
Ma, M.-Z., Chu, B.-F., Zhang, Y., Weng, M.-Z., Qin, Y.-Y., Gong, W., & Quan, Z.-W. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.541 · Cited by 328
Choudhry, H., Albukhari, A., Morotti, M., Haider, S., Moralli, D., Smythies, J., Schödel, J., Green, C. M., Camps, C., Buffa, F., et al. (2015) · Oncogene · doi:10.1038/onc.2014.378 · Cited by 316
Molecular Genetics of Lung Cancer
Sekido, Y., Fong, K. M., & Minna, J. D. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152202 · Cited by 313
Fox, A. H., & Lamond, A. I. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000687 · Cited by 302
Cyclin D1 in non-small cell lung cancer: A key driver of malignant transformation
Gautschi, O., Ratschiller, D., Gugger, M., Betticher, D. C., & Heighway, J. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2006.09.024 · Cited by 243
Expression and prognostic impact of lncRNAs in acute myeloid leukemia
Garzon, R., Volinia, S., Papaioannou, D., Nicolet, D., Kohlschmidt, J., Yan, P. S., Mrózek, K., Bucci, D., Carroll, A. J., Baer, M. R., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422050112 · Cited by 233
Paraspeckle formation during the biogenesis of long non-coding RNAs
Naganuma, T., & Hirose, T. (2013) · RNA Biology · doi:10.4161/rna.23547 · Cited by 218
The RNA Degradation Pathway Regulates the Function of GAS5 a Non-Coding RNA in Mammalian Cells
Tani, H., Torimura, M., & Akimitsu, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055684 · Cited by 173
Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis
Zhen, L., Yun-hui, L., Hong-yu, D., Jun, M., & Yi-long, Y. (2016) · Tumor Biology · doi:10.1007/s13277-015-3843-y · Cited by 162
Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome
Foster, C. S., Falconer, A., Dodson, A. R., Norman, A. R., Dennis, N. M., Fletcher, A., Southgate, C., Dowe, A., Dearnaley, D. P., Jhavar, S. G., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207800 · Cited by 154
Decapping of Long Noncoding RNAs Regulates Inducible Genes
Geisler, S., Lojek, L. J., Khalil, A. M., Baker, K. E., & Coller, J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.11.025 · Cited by 135
Olsson, A. Y., Feber, A., Edwards, S. E., Poele, R. T., Giddings, I., Merson, S., & Cooper, C. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209854 · Cited by 130
Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development
Sun, C., Huang, C., Li, S., Yang, C., Xi, Y., Wang, L., Zhang, F., Fu, Y., & Li, D. (2016) · Oncotarget · doi:10.18632/oncotarget.7071 · Cited by 120
Self-citationSun, C., Liu, Z., Li, S., Yang, C., Xue, R., Xi, Y., Wang, L., Wang, S., He, Q., Huang, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4575 · Cited by 117
Self-citationSun, C., Li, S., Yang, C., Xi, Y., Wang, L., Zhang, F., & Li, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.175 · Cited by 115
Self-citationChoudhry, H., Albukhari, A., Morotti, M., Haider, S., Moralli, D., Smythies, J., Schödel, J., Green, C., Camps, C., Buffa, F., et al. (2015) · Oncogene · doi:10.1038/onc.2014.431 · Cited by 108
Paraspeckle nuclear bodies—useful uselessness?
Nakagawa, S., & Hirose, T. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0973-x · Cited by 103
Sun, C., Li, S., & Li, D. (2016) · Oncotarget · doi:10.18632/oncotarget.8482 · Cited by 100
Self-citationNie, F., Zhu, Q., Xu, T., Zou, Y.-F., Xie, M., Sun, M., Xia, R., & Lu, K. (2014) · Tumor Biology · doi:10.1007/s13277-014-2009-7 · Cited by 97
Upregulation and Clinicopathological Significance of Long Non-coding NEAT1 RNA in NSCLC Tissues
Pan, L., Zhong, T.-F., Tang, R., Li, P., Dang, Y., Huang, S., & Chen, G. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.7.2851 · Cited by 92
Nuclear overexpression of the E2F3 transcription factor in human lung cancer
Cooper, C. S., Nicholson, A. G., Foster, C. S., Dodson, A. R., Edwards, S. E., Fletcher, A., Roe, T., Clark, J., Joshi, A., Norman, A. R., et al. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.07.005 · Cited by 88
Zeng, X., Shaikh, F. Y., Harrison, M. K., Adon, A. M., Trimboli, A. J., Carroll, K. A., Sharma, N., Timmers, C. D., Chodosh, L. A., Leone, G. W., et al. (2010) · Oncogene · doi:10.1038/onc.2010.253 · Cited by 79
MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma
Zehavi, L., Schayek, H., Jacob‐Hirsch, J., Sidi, Y., Leibowitz‐Amit, R., & Avni, D. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0338-9 · Cited by 77
Vieira, F. Q., Costa‐Pinheiro, P., Almeida-Rios, D., Graça, I. C. R., Monteiro‐Reis, S., Simoes‐Sousa, S., Carneiro, I. C., Sousa, E., Godinho, M. I., Baltazar, F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3767 · Cited by 77
Sun, C., Li, S., Zhang, F., Pan, J., Wang, L., Yang, C.-L., Xi, Y., & Li, D. (2016) · Oncotarget · doi:10.18632/oncotarget.7517 · Cited by 68
Self-citationState of the Art in Therapy for Non-Small Cell Lung Cancer
Laskin, J. J., & Sandler, A. B. (2005) · Cancer Investigation · doi:10.1081/cnv-200067172 · Cited by 64
Small RNAs and Non-Small Cell Lung Cancer
Tong, A. (2006) · Current Molecular Medicine · doi:10.2174/156652406776894554 · Cited by 51
Integrative analysis of microRNA and mRNA expression profiles in non-small-cell lung cancer
Yang, C., Sun, C., Liang, X., Xie, S. T., Huang, J., & Li, D. (2016) · Cancer Gene Therapy · doi:10.1038/cgt.2016.5 · Cited by 48
Self-citationBarnhill, L. M., Williams, R. T., Cohen, O., Kim, Y.-J., Batova, A., Mielke, J. A., Messer, K. S., Pu, M., Bao, L., Yu, A. L.-T., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3447 · Cited by 46
miR-377 functions as a tumor suppressor in human clear cell renal cell carcinoma by targeting ETS1
Wang, R., Ma, Y., Yu, D., Zhao, J., & Ma, P. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.01.012 · Cited by 44
Rady, B., Chen, Y., Vaca, P., Wang, Q., Wang, Y., Salmon, P., & Oberholzer, J. (2013) · Cell Cycle · doi:10.4161/cc.25834 · Cited by 30
Cited by
Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine
Wen, S., Wei, Y., Zen, C., Xiong, W., Niu, Y., & Zhao, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01293-4 · Cited by 259
Metadata
- Authors
- Sun, C., Li, S., Zhang, F., Xi, Y., Wang, L., Bi, Y., & Li, D.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-06-16
- Volume
- 7
- Issue
- 32
- Pages
- 51784-51814
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2420947713
- Cited by
- 312
- References
- 73
- FWCI
- 23.53
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.